Phase I Clinical Development of RespiFect™ Inhalation System: Treatment of Pulmonary Aspergillosis

Pulmonary Aspergillosis is a life-threatening infection with significant unmet medical needs in hospital use. Pentamycin has shown strong in-vitro action against the Aspergillosis fungal species. More …